Equillium (EQ) Interest Coverage Ratio (2018 - 2023)
Equillium (EQ) posted quarterly Interest Coverage Ratio of 0.53 for Q1 2026, up 99.43% year-over-year from 0.26 in Q1 2025, and up 99.48% quarter-over-quarter from 101.59 in Q4 2025.
Powered by 
Analysis
Equillium (EQ) Interest Coverage Ratio (2018 - 2023) Analysis & Trends
Equillium (EQ) has reported Interest Coverage Ratio for 9 consecutive years, with 0.53 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 99.43% year-over-year to 0.53; the TTM figure through Mar 2026 stood at 1.91 (up 87.91% YoY), while the FY2025 annual figure was 0.43, down 166.12% from the prior year.
- Interest Coverage Ratio climbed to 0.53 in Q1 2026 per EQ's latest filing, from 101.59 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 31.42 in Q4 2022 and bottomed at 101.59 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 25.14 across 5 years, with a median of 12.37 in 2023.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 108.77% — and 2025, when it sank 44813.45%.
- Equillium's Interest Coverage Ratio stood at 31.42 in 2022, then tumbled by 122.39% to 7.03 in 2023, then sank by 443.09% to 38.2 in 2024, then sank by 165.98% to 101.59 in 2025, then jumped by 99.48% to 0.53 in 2026.
- Business Quant data shows EQ's Interest Coverage Ratio at 0.53 in Q1 2026, 101.59 in Q4 2025, and 1.04 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Equillium | 249.33 Mn | 249.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -13.86 |
| Mar 31, 2023 | -17.71 |
| Dec 31, 2022 | 7.54 |
| Sep 30, 2022 | -49.58 |
| Jun 30, 2022 | -52.32 |
| Mar 31, 2022 | -146.39 |
| Dec 31, 2021 | -39.05 |
| Sep 30, 2021 | -37.07 |
| Jun 30, 2021 | -32.75 |
| Mar 31, 2021 | -32.08 |
| Dec 31, 2020 | -32.50 |
| Sep 30, 2020 | -23.61 |
| Jun 30, 2020 | -24.12 |
| Mar 31, 2020 | -27.30 |
| Dec 31, 2019 | -27.49 |
| Sep 30, 2019 | -3,162.00 |
| Dec 31, 2018 | -18.46 |
| Sep 30, 2018 | -1.82 |
| Jun 30, 2018 | -1.82 |
| Mar 31, 2018 | -2.12 |